Ken Griffin Kamada LTD Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Kamada LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 100 shares of KMDA stock, worth $689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 200
50.0%
Holding current value
$689
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding KMDA
# of Institutions
26Shares Held
6.11MCall Options Held
100Put Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.83MShares$12.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$9.66 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$5.73 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA631KShares$4.35 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3499KShares$3.44 Million0.27% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $309M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...